Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …
COVID-19: Transmission, prevention, and potential therapeutic opportunities
M Lotfi, MR Hamblin, N Rezaei - Clinica chimica acta, 2020 - Elsevier
The novel coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Despite intense …
syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Despite intense …
[HTML][HTML] Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes
COVID-19 is characterized by excessive production of pro-inflammatory cytokines and acute
lung damage associated with patient mortality. While multiple inflammatory cytokines are …
lung damage associated with patient mortality. While multiple inflammatory cytokines are …
The role of NO in COVID-19 and potential therapeutic strategies
Nitric oxide (NO) is a free radical playing an important pathophysiological role in
cardiovascular and immune systems. Recent studies reported that NO levels were …
cardiovascular and immune systems. Recent studies reported that NO levels were …
Platelet in thrombo-inflammation: Unraveling new therapeutic targets
In the broad range of human diseases, thrombo-inflammation appears as a clinical
manifestation. Clinically, it is well characterized in context of superficial thrombophlebitis that …
manifestation. Clinically, it is well characterized in context of superficial thrombophlebitis that …
Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms
Nitric oxide (NO) is a gasotransmitter of great significance to developing the innate immune
response to many bacterial and viral infections, while also modulating vascular physiology …
response to many bacterial and viral infections, while also modulating vascular physiology …
[HTML][HTML] Nitric oxide (NO) and nanoparticles–potential small tools for the war against COVID-19 and other human coronavirus infections
The endogenous free radical nitric oxide (NO) plays a pivotal role in the immunological
system. NO has already been reported as a potential candidate for use in the treatment of …
system. NO has already been reported as a potential candidate for use in the treatment of …
Nitric oxide: clinical applications in critically ill patients
Inhaled nitric oxide (iNO) acts as a selective pulmonary vasodilator and it is currently
approved by the FDA for the treatment of persistent pulmonary hypertension of the newborn …
approved by the FDA for the treatment of persistent pulmonary hypertension of the newborn …
The potential role of nitric oxide as a therapeutic agent against SARS-CoV-2 infection
S Xiao, Z Yuan, Y Huang - International Journal of Molecular Sciences, 2023 - mdpi.com
The global coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the greatest worldwide …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the greatest worldwide …